Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
ASND
Showing 0 of 2 quarters
Position history for Assenagon Asset Management S.A.'s holdings in Ascendis Pharma A/S
No. Assenagon Asset Management exited its ASND (Ascendis Pharma) position in Q3 2022. Its Q2 2022 13F listed 276,348 shares worth $25.7M. Assenagon Asset Management first reported ASND in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.